(888) 391-1315

53ab241127ee4a612ed1b0c0_Icon-arrow-top.png

DRUG SAFETY
THROUGH AWARENESS.

Find the latest news on prescription medications and medical devices including new releases, what's popular or under warning. 

find your drug or device

Studies & Warnings For Top Pharma Products

Valuable published reports from the FDA and top researchers about potential drug side effects and defective products.

find your drug or device

helpful Stories From Real Patients

Has your drug caused others to experience similar side effects? Hear stories about potential side effects that you may be suffering from.

read similar experiences

Litigation and Settlement News

Find out if your drug has side effects that are being litigated and see if you might have a case. What could it be worth? 

find out now!

Drug safety though awareness.

View ›

Studies & Warnings for Top Products

View ›

Stories from Real Patients

View ›

Litigation & Settlement News

View ›

Latest news

FDA Withdraws Approval of Four Cholesterol Drugs
Friday, April 29, 2016

The U.S. Food and Drug Administration took the unusual step this week of withdrawing its approval of four medications used to treat high cholesterol, based on studies that show the benefits of the drugs no longer outweighed the risks.

The change will affect drugs containing niacin, also known as vitamin B-3, and/or fenofibric acid, when the medications are combined with statins.

Read more

Second Trial Over Talcum Baby Powder Ovarian Cancer Begins in MO
Thursday, April 14, 2016

Just weeks after a St. Louis jury ordered Johnson & Johnson to pay $72 million to the family of a woman who died of ovarian cancer after years of using the company’s baby powder products, the second baby powder trial in the Missouri court has started.

This week, the trial began in a lawsuit filed by Gloria Ristesund, a woman diagnosed with ovarian cancer after using Johnson & Johnson’s talcum powder products for 40 years.

Read more

FDA Warns of Heart Risks in Onglyza, Nesina Diabetes Drugs
Thursday, April 07, 2016

Two popular type-2 diabetes drugs are in the news after the FDA warned this week that patients taking them may face higher risks of heart failure.

The new warning, issued Tuesday, focuses on the DPP-4 inhibitors Onglyza (saxagliptin), sold by AstraZeneca, and Nesina (alogliptin), sold by Takeda. Together, these drugs are prescribed more than 3 million times each year.

Read more

About DRUGNEWS.

Millions of patients use prescription drugs or medical devices every day, trusting that these products are safe and have been properly tested. Sadly, this is not always the case. Thousands of families are affected by drug injury or death each year.

Many consumers don’t know that pharmaceutical companies and the FDA do not disclose all drug side effects or independent research of the safety of these products. They also may not know that millions of dollars are awarded each year to help those injured.

DrugNews provides the latest research, warnings, FDA recalls and legal news to those who use popular drugs or medical devices. Informed patients can compare their side effects with others and determine questions for their doctor. In addition, we can help those affected learn more about their legal options or speak with a qualified lawyer.

more about us
MILLIONS USE PRESCRIPTION DRUGS
THOUSANDS ARE AFFECTED BY INJURY OR DEATH
WE DISCLOSE SIDE EFFECTS, NEWS & RECALLS
WE ASSIST PATIENTS AFFECTED

In short:

  • 5452ac8f59e96dbc0feb2f63_check-icon.png

    Top notch research on products you’re using

  • 5452ac8f59e96dbc0feb2f63_check-icon.png

    Updates & news on side effects and injuries

  • 5452ac8f59e96dbc0feb2f63_check-icon.png

    Medical and legal support for you

prescription drugs

bad drugs

Thousands of prescription drugs have been linked to side effects, but some of these are so severe they lead to recalls or restricted use. Learn if your medicine is included.

medical devices

recalled devices

In recent years the FDA and manufacturers have recalled several popular medical implants or surgical devices due to a heightened risk of injury or death.

claim assistance

claim assistance

DrugNews can help you navigate the challenging process of filing a claim for your drug or medical device injury. Lawyers are available to talk for free today.